Skip to content
Review Open access

Pathophysiology of Geographic Atrophy: RPE or Choroid as the Primary Culprit?

Sep 2026 · Journal of Molecular Pathology · Vol 7, pp. 33 · 0 citations · 38 references

TL;DR

This analysis explores the paradigm that GA represents a synergistic failure of the outer blood–retinal barrier—a symbiotic trophic unit highly dependent on precise vascular and epithelial crosstalk, tightly regulated complement cascades, and extracellular matrix integrity.

Abstract

Age-related macular degeneration (AMD) remains the leading cause of irreversible, severe visual loss among elderly populations in industrialized nations. The clinical spectrum ranges from early forms, characterized by the accumulation of extracellular deposits known as drusen, to advanced, vision-threatening late stages. While anti-vascular endothelial growth factor (anti-VEGF) therapy for neovascular AMD is the standard of care, geographic atrophy has remained a progressive condition. Geographic atrophy is a chronic neurodegenerative disease defined pathologically by the concurrent, progressive loss of the retinal pigment epithelium (RPE), the overlying photoreceptors, and the underlying choriocapillaris. Historically, the diagnosis and monitoring of GA relied on color fundus photography, which identified the lesions as sharply demarcated, well-circumscribed round or oval areas of depigmentation through which underlying choroidal vessels became clinically visible. However, the advent of high-resolution multimodal imaging—particularly fundus autofluorescence (FAF) and optical coherence tomography (OCT)—has necessitated a modernization of this terminology. Despite the imaging consensus, the fundamental pathophysiology of GA remains the subject of intense academic and clinical debate. The controversy focuses on identifying the primary cellular culprit responsible for initiating the cascade of degeneration. The “top-down” hypothesis suggests that intracellular metabolic failure, oxidative stress, and senescence within the RPE trigger the secondary dysfunction and death of the adjacent photoreceptors and choriocapillaris. Conversely, the “bottom-up” vascular hypothesis argues that age-related and complement activation–driven hemodynamic insufficiency, ischemic dropout, and structural involution of the choriocapillaris precede RPE dysfunction, creating a hypoxic microenvironment that drives the subsequent epithelial collapse. This narrative review scrutinizes the exact molecular, genetic, and structural mechanisms governing the expansion of geographic atrophy. By dissecting the evidence supporting both the RPE and the choriocapillaris as primary instigators, this analysis explores the paradigm that GA represents a synergistic failure of the outer blood–retinal barrier—a symbiotic trophic unit highly dependent on precise vascular and epithelial crosstalk, tightly regulated complement cascades, and extracellular matrix integrity.

Read PDF

Similar papers

Review Open access Aug 2026

Pigment Epithelial Detachement: Pathophysiology, Diagnosis, and Treatments

Pigment epithelial detachment (PED) is an important manifestation in various retinal diseases, particularly age-related macular degeneration (AMD), and has a significant impact on visual function decline. PED is associated with structural alterations of the retinal pigment epithelium (RPE) and plays a crucial role in d...

Santi Anugrahsari, Cornelia Louisa Maria Sunur, Margie Adelila Apriliani Usfunan · 0 citations
Open access Aug 2026

Regional growth kinetics of geographic atrophy in age-related macular degeneration with and without fovea-sparing.

PURPOSE Fovea-sparing geographic atrophy (GA) patients retain near-normal central vision. To better understand GA progression in relation to the fovea, we performed a semi-automated image analysis of regional atrophy growth in a long-term GA natural-history cohort. METHODS Prospective-observational, single-centre-stu...

D. Muth, A. Venkataraman, Alberto Domínguez-Vicent et al. · 0 citations
Review Open access Sep 2026

From Intermediate AMD to Geographic Atrophy: Biomarkers, Endpoints, and a Roadmap for Next-Generation Clinical Trials.

Age-related macular degeneration (AMD) is a leading cause of irreversible legal blindness worldwide. Treatments exist for late-stage AMD, but none exists for the intermediate stage (iAMD), which precedes significant vision loss. A therapy tested in iAMD would aim to prevent or slow progression to late-stage disease, me...

Alessandro Berni, P. Rosenfeld, D. Bacherini et al. · 0 citations
Review Aug 2026

Is extensive macular atrophy with pseudodrusen a variant of age-related macular degeneration? New insights from the first multiethnic, multicentreU.S. cohort.

OBJECTIVE To characterize the long-term clinical and multimodal imaging (MMI) features of extensive macular atrophy with pseudodrusen (EMAP) in a U.S. COHORT DESIGN Multicentre retrospective case series. PARTICIPANTS Patients diagnosed with EMAP between 2015 and 2025. METHODS Clinical records and MMI-including...

Alessandro Feo, Alberto Quarta, P. Ramtohul et al. · 1 citation
Review Aug 2026

Retinal Pigment Epithelial Detachment: Molecular Mechanisms, Multimodal Imaging Classification, and Clinical Management Across the Spectrum of Macular Disease.

Pigment epithelial detachment (PED) represents a critical structural finding across the spectrum of chorioretinal diseases, occurring in 63-80% of eyes with neovascular age-related macular degeneration and frequently in central serous chorioretinopathy, polypoidal choroidal vasculopathy, and inflammatory conditions. Th...

Pasquale Viggiano, Maria Grazia Pignataro, Alba Chiara Termite et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.